After engrafted with CtrlKD or ATP6AP2KD SW620 or DLD1 cells, the mice were treated with a monoclonal antibody blocking CD47-SIRPα interaction, and tumor development was quantified via bioluminescence imaging. This evidence concerns the gene SIRPA and neoplasm.